268 related articles for article (PubMed ID: 9833620)
1. Effects of multiagent chemotherapy and independent risk factors in the treatment of high-risk GTT--25 years experiences of KRI-TRD.
Kim SJ; Bae SN; Kim JH; Kim CT; Han KT; Lee JM; Jung JK
Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S85-96. PubMed ID: 9833620
[TBL] [Abstract][Full Text] [Related]
2. Effects of multiagent chemotherapy and independent risk factors in the treatment of high-risk GTT -25 years experiences of KRI-TRD.
Kim SJ; Bae SN; Kim JH; Kim CT; Han KT; Lee JM; Jung JK
Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S85-S96. PubMed ID: 29645247
[TBL] [Abstract][Full Text] [Related]
3. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
[TBL] [Abstract][Full Text] [Related]
4. EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT).
Bolis G; Bonazzi C; Landoni F; Mangili G; Vergadoro F; Zanaboni F; Mangioni C
Gynecol Oncol; 1988 Nov; 31(3):439-44. PubMed ID: 2846414
[TBL] [Abstract][Full Text] [Related]
5. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.
McNeish IA; Strickland S; Holden L; Rustin GJ; Foskett M; Seckl MJ; Newlands ES
J Clin Oncol; 2002 Apr; 20(7):1838-44. PubMed ID: 11919242
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for the prediction of treatment failure in gestational trophoblastic tumors treated with EMA/CO regimen.
Kim SJ; Bae SN; Kim JH; Kim CJ; Jung JK
Gynecol Oncol; 1998 Nov; 71(2):247-53. PubMed ID: 9826467
[TBL] [Abstract][Full Text] [Related]
7. EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients.
Bower M; Newlands ES; Holden L; Short D; Brock C; Rustin GJ; Begent RH; Bagshawe KD
J Clin Oncol; 1997 Jul; 15(7):2636-43. PubMed ID: 9215835
[TBL] [Abstract][Full Text] [Related]
8. The management of high-risk gestational trophoblastic tumours (GTT).
Newlands ES; Bower M; Holden L; Short D; Brock C; Rustin GJ; Begent RH; Bagshawe KD
Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S65-70. PubMed ID: 9833617
[TBL] [Abstract][Full Text] [Related]
9. [EMA/CO regimen for chemotherapy 24 patients with ultra high-risk gestational trophoblastic neoplasia].
Shen T; Chen LL; Qin JL; Wang XY; Cheng XD; Xie X; Lyu WG
Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):371-376. PubMed ID: 29961278
[No Abstract] [Full Text] [Related]
10. Combination chemotherapy for high-risk gestational trophoblastic tumour.
Deng L; Yan X; Zhang J; Wu T
Cochrane Database Syst Rev; 2009 Apr; (2):CD005196. PubMed ID: 19370618
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy for high-risk gestational trophoblastic tumour.
Xue Y; Zhang J; Wu TX; An RF
Cochrane Database Syst Rev; 2006 Jul; (3):CD005196. PubMed ID: 16856085
[TBL] [Abstract][Full Text] [Related]
12. Management of high-risk hydatidiform mole and persistent gestational trophoblastic neoplasia: the Korean experience.
Kim SJ; Na YJ; Jung SG; Kim CJ; Bae SN; Lee C
J Reprod Med; 2007 Sep; 52(9):819-30. PubMed ID: 17939600
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy with 5-fluorouracil, methotrexate and etoposide for patients with high-risk gestational trophoblastic tumors: a report based on our 11-year clinical experiences.
Wang S; An R; Han X; Zhu K; Xue Y
Gynecol Oncol; 2006 Dec; 103(3):1105-8. PubMed ID: 16870237
[TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy for primary treatment of high-risk gestational trophoblastic tumour.
Deng L; Zhang J; Wu T; Lawrie TA
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD005196. PubMed ID: 23440800
[TBL] [Abstract][Full Text] [Related]
15. Developments in chemotherapy for medium- and high-risk patients with gestational trophoblastic tumours (1979-1984).
Newlands ES; Bagshawe KD; Begent RH; Rustin GJ; Holden L; Dent J
Br J Obstet Gynaecol; 1986 Jan; 93(1):63-9. PubMed ID: 3002420
[TBL] [Abstract][Full Text] [Related]
16. Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989.
Newlands ES; Bagshawe KD; Begent RH; Rustin GJ; Holden L
Br J Obstet Gynaecol; 1991 Jun; 98(6):550-7. PubMed ID: 1651757
[TBL] [Abstract][Full Text] [Related]
17. High-risk metastatic gestational trophoblastic disease. A new dose-intensive, multiagent chemotherapeutic regimen.
Surwit EA; Childers JM
J Reprod Med; 1991 Jan; 36(1):45-8. PubMed ID: 1848900
[TBL] [Abstract][Full Text] [Related]
18. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
Lurain JR; Singh DK; Schink JC
J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
[TBL] [Abstract][Full Text] [Related]
19. Clinical epidemiology and management of gestational trophoblastic neoplasia in Hungary in the past 34 years.
Fülöp V; Szigetvári I; Szepesi J; Végh G; Singh M; Berkowitz RS
J Reprod Med; 2012; 57(7-8):310-8. PubMed ID: 22838247
[TBL] [Abstract][Full Text] [Related]
20. Management of resistant gestational trophoblastic tumors.
Newlands ES; Bower M; Holden L; Short D; Seckl MJ; Rustin GJ; Begent RH; Bagshawe KD
J Reprod Med; 1998 Feb; 43(2):111-8. PubMed ID: 9513872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
